Geertruida N. Jonges

Utrecht, UT 3508GA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Long-term prognostic value of staging surgery for high-intermediate-risk and high-risk endometrial cancer.

Long-term prognostic value of staging surgery for high-intermediate-risk and high-risk endometrial cancer.

Journal: Journal of robotic surgery

Published: January 13, 2026

GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.

GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.

Journal: Virchows Archiv : an international journal of pathology

Published: March 14, 2025

Signal transduction pathway activity in adult-type granulosa cell tumor samples.

Signal transduction pathway activity in adult-type granulosa cell tumor samples.

Journal: Gynecologic oncology

Published: December 24, 2024

Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?

Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?

Journal: Journal of ovarian research

Published: December 20, 2024

Effect of uterine manipulator on oncologic outcome in early-stage, low-grade endometrial cancer.

Effect of uterine manipulator on oncologic outcome in early-stage, low-grade endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 18, 2024

Artificial Intelligence-Based Sentinel Lymph Node Metastasis Detection in Cervical Cancer.

Artificial Intelligence-Based Sentinel Lymph Node Metastasis Detection in Cervical Cancer.

Journal: Cancers

Published: August 27, 2024

Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early-stage high-intermediate or high-risk endometrial cancer.

Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early-stage high-intermediate or high-risk endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 17, 2024

Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high-intermediate or high-risk endometrial cancer.

Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high-intermediate or high-risk endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 01, 2024

Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review.

Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review.

Journal: Cancers

Published: January 31, 2024

Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study.

Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study.

Journal: BMJ open

Published: September 13, 2022

Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.

Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.

Journal: Gynecologic oncology

Published: December 08, 2021

[18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary.

[18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary.

Journal: Oncotarget

Published: January 30, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026